CD276 and acute lymphoblastic leukemia: We also found that miR-582 overexpression promotes the expression of CD276 and protects BCP-ALL cells from NK cell-mediated cytotoxicity, which can be overcome by CD276 blockade with a specific antibody (Figure 6F).